Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
interferon alfacon-1 interferon alpha/beta receptor 1 biotech NA drugbank , DGIDB Hairy Cell Leukemia[MeSHID:D007943]
melanoma[MeSHID:D008545]
AIDS with Kaposi's sarcoma[MeSHID:C554498]
Cutaneous Melanoma[MeSHID:C562393]
Hepatitis C[MeSHID:D006526]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 2.65 approved,investigational binder,agonist
interferon alfacon-1 interferon alpha/beta receptor 1 biotech NA drugbank , DGIDB Hairy Cell Leukemia[MeSHID:D007943]
melanoma[MeSHID:D008545]
AIDS with Kaposi's sarcoma[MeSHID:C554498]
Cutaneous Melanoma[MeSHID:C562393]
Hepatitis C[MeSHID:D006526]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational binder
interferon alfacon-1 interferon alpha/beta receptor 2 biotech Successful target TTD , drugbank , DGIDB Hairy Cell Leukemia[MeSHID:D007943]
melanoma[MeSHID:D008545]
AIDS with Kaposi's sarcoma[MeSHID:C554498]
Cutaneous Melanoma[MeSHID:C562393]
Hepatitis C[MeSHID:D006526]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 2.65 approved,investigational binder,agonist
interferon alfacon-1 interferon alpha/beta receptor 2 biotech Successful target TTD , drugbank , DGIDB Hairy Cell Leukemia[MeSHID:D007943]
melanoma[MeSHID:D008545]
AIDS with Kaposi's sarcoma[MeSHID:C554498]
Cutaneous Melanoma[MeSHID:C562393]
Hepatitis C[MeSHID:D006526]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational binder
click here to return to the previous page